Dubai Health takes a breakthrough in the molecular treatment of prostate cancer

Doctors at the Dubai Hospital have successfully treated the first case of prostate cancer for a seventh-decade citizen through molecular therapy at Dubai's Nuclear Medicine and Molecular Imaging Center, to the first time at the regional level after the introduction to the hospital of the molecular imaging technique LU-177-PSMA

"The patient had been in bed for a long time and after weeks of treatment, his condition had improved significantly after the first dose, and he can now walk and do his daily activities," said Dr. Batul al-Boshi, consultant in nuclear medicine and molecular imaging. The hormone produced by cancer cells from 140 to 80 years old should respond to treatment in the coming weeks, which is a major step forward in the treatment of prostate cancer patients in the country, the One of the most important cancer diseases prevalent in men.

Mechanism

"Before the start of molecular therapy, the Dubai Center for Nuclear Medicine and Positron Imaging had begun to prepare for the addition of the first and only state-of-the-art service for the diagnosis of prostate tumors in the United States. This test makes it easy to determine the location of the tumor and its spread in the body, for the imaging of prostate tumors made up of very short-lived radioactive material, Galium 68 has been provided by the health authority and is not available in other centers and sections of the state and in many countries in the region.

And has shown that the new material only attracts the receptors in the prostate cells and gives a signal to accurately portray the location of the tumor to be diagnosed, to allow medical intervention at an early stage of the disease. The service was launched in May 2018 and has filmed more than 30 cases in less than three months. The earliest sections and centers of the state and countries in the region have used this type of diagnostic imaging in tumors.

She explained that the body had begun to set up the molecular treatment unit for prostate cancer using advanced methods and using new molecular and radial isotopes early this year, noting that the Center's Dubai Nuclear Medicine and Molecular Imaging had begun treatment in Dubai as a major collaboration between the Department of Oncology and the Dubai Nuclear Medicine Center. .

Molecular therapy is the best option for a patient who has a spread of the disease in the body and who has not responded to chemotherapy. Treatment consists of an internal irradiation of cancer cells by injection of a drug. dose of intravenous radioisotopes, repeated every 6 to 8 weeks according to the same procedures.

Indicators

She pointed out that one of the most important indicators of the success of molecular therapy is the identification and monitoring of hormone produced by prostate tumor cells.

She added that doctors followed patients with blood tests and periodically and regularly checked all vital blood results, stressing that this type of treatment could be performed without the need to introduce patients because the type of radiation used was beta and this type of radiation and exposure range was very short for the surrounding people. Tags.

"Following this success, the Dubai Molecular Therapy Center is now preparing to accept and receive patients from abroad, which is in line with the Dubai government's tourism treatment policies," he said. she declared.